← All organizations

Allos Therapeutics

For profitContributed to NME

Also known as: ALLOS | Allos Biopharma

Phase 1 Phase 2 Phase 3 Phase 4

First marketed drug

First NDA

Last known activity

Sep 24, 2009

Acquired by Spectrum Pharmaceuticals → Repligen Corporation on Sep 6, 2012

Timeline

1990s

Jul 1, 1992
Allos Therapeutics— Founded

2000s

Sep 24, 2009
pralatrexate— NDA Organization

2010s

Sep 6, 2012
Spectrum Pharmaceuticals— Acquired By
Jun 27, 2017
Repligen Corporation— Now

Indications

Approved for

Lymphoma, T-Cell, Peripheral

Marketed drugs (1)

pralatrexate

Details

Founded: South San Francisco, CA, US Jul 1, 1992
First NDA: Sep 24, 2009
Last known activity: Sep 24, 2009

Designations held

Orphan drug
Priority review
Accelerated approval

Notes

Acquired by Spectrum 6 Sept 2012